Research Topics
| David M BrizelSummaryAffiliation: Duke University Medical Center Country: USA Publications
| Collaborators
|
Detail Information
Publications
Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinomaDavid M Brizel
Department of Radiation Oncology, Duke University, Durham, NC, USA
J Clin Oncol 26:2489-96. 2008..This study assessed the efficacy and safety of palifermin in patients receiving concurrent chemoradiotherapy for advanced head and neck squamous cell carcinoma...
Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancerD M Brizel
Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA
Int J Radiat Oncol Biol Phys 51:349-53. 2001..We assessed the relationship between pretreatment tumor lactate concentrations and subsequent development of metastatic disease in patients with newly diagnosed head-and-neck cancer...
Does amifostine have a role in chemoradiation treatment?David M Brizel
Department of Radiation Oncology at Duke University Medical Center, NC, USA
Lancet Oncol 4:378-81. 2003....
Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancerDavid M Brizel
Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA
Int J Radiat Oncol Biol Phys 58:1418-23. 2004..The necessity for postchemoradiation neck dissection is controversial. The intent of this report was to define the value of neck dissection in this patient population better...
Phase III randomized trial of amifostine as a radioprotector in head and neck cancerD M Brizel
Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA
J Clin Oncol 18:3339-45. 2000..This randomized trial evaluated whether amifostine could ameliorate these side effects without compromising the effectiveness of radiotherapy in these patients...
Pharmacologic approaches to radiation protectionDavid M Brizel
Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA
J Clin Oncol 25:4084-9. 2007..Pharmacologic radioprotective strategies should be integrated with physical strategies such as intensity-modulated radiotherapy to realize their maximum clinical potential...
Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neckD M Brizel
Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA
Int J Radiat Oncol Biol Phys 38:285-9. 1997..This study was performed to evaluate the relationship between tumor hypoxia and DFS in patients with squamous carcinoma of the head and neck (SCCHN)...
Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcomaD M Brizel
Department of Radiation Oncology, Duke University Comprehensive Cancer Center, Durham, North Carolina, 27710, USA
Cancer Res 56:941-3. 1996..Median pO2 was 7.5 mm Hg for metastasizing tumors versus 20 mm Hg for nonmetastasizing tumors (P=0.03). Potential mechanisms and implications for clinical trial design are discussed...
Prospective trial of synchronous bevacizumab, erlotinib, and concurrent chemoradiation in locally advanced head and neck cancerDavid S Yoo
Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina 27710, USA
Clin Cancer Res 18:1404-14. 2012..We assessed the safety and efficacy of synchronous VEGF and epidermal growth factor receptor (EGFR) blockade with concurrent chemoradiation (CRT) in locally advanced head and neck cancer (HNC)...
Assessment of the protective effect of amifostine on radiation-induced pulmonary toxicityZeljko Vujaskovic
Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina 27710, USA
Exp Lung Res 28:577-90. 2002....
The effect of darbepoetin alfa on growth, oxygenation and radioresponsiveness of a breast adenocarcinomaJohn P Kirkpatrick
Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina 27710, USA
Radiat Res 165:192-201. 2006..In this nonanemic animal model of mammary adenocarcinoma, darbepoetin alfa does not significantly alter tumor growth or radioresponsiveness, even though it improves oxygenation when administered at high doses...
Pretreatment anemia is correlated with the reduced effectiveness of radiation and concurrent chemotherapy in advanced head and neck cancerRobert G Prosnitz
Department of Radiation Oncology, Box 3085, Duke University Medical Center, Durham, NC 27710, USA
Int J Radiat Oncol Biol Phys 61:1087-95. 2005..This study was performed to evaluate whether pretreatment Hgb less than 13 g/dL was correlated with treatment outcome in patients with advanced HNC treated with a uniform regimen of RT/CCT...
The protective effect of recombinant human keratinocyte growth factor on radiation-induced pulmonary toxicity in ratsLiguang Chen
Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA
Int J Radiat Oncol Biol Phys 60:1520-9. 2004..These data also support the use of rHuKGF in a clinical trial designed to prevent radiation-induced lung injury...
Recent progress in defining mechanisms and potential targets for prevention of normal tissue injury after radiation therapyMitchell S Anscher
Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA
Int J Radiat Oncol Biol Phys 62:255-9. 2005..With the application of a better understanding of fundamental biology to clinical practice, new approaches to treating and preventing normal tissue injury can focus on correcting these disturbed molecular processes...
Relation between pO2, 31P magnetic resonance spectroscopy parameters and treatment outcome in patients with high-grade soft tissue sarcomas treated with thermoradiotherapyMark W Dewhirst
Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA
Int J Radiat Oncol Biol Phys 61:480-91. 2005....
Analysis of pretreatment FDG-PET SUV parameters in head-and-neck cancer: tumor SUVmean has superior prognostic valueKristin A Higgins
Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA
Int J Radiat Oncol Biol Phys 82:548-53. 2012..To evaluate the prognostic significance of different descriptive parameters in head-and-neck cancer patients undergoing pretreatment [F-18] fluoro-D-glucose-positron emission tomography (FDG-PET) imaging...
Tumor-dependent kinetics of partial pressure of oxygen fluctuations during air and oxygen breathingL Isabel Cardenas-Navia
Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina 27710, USA
Cancer Res 64:6010-7. 2004..Fluctuations of pO2 of the type reported herein are predicted to significantly affect radiotherapy response and could be a source for genetic instability, increased angiogenesis, and metastases...
Human recombinant erythropoietin significantly improves tumor oxygenation independent of its effects on hemoglobinKimberly L Blackwell
Division of Medical Oncology, Department of Medicine, Duke University Comprehensive Cancer Center, Erwin Road, Durham, NC 27710, USA
Cancer Res 63:6162-5. 2003..These data confirm that tumor oxygenation in nonanemic individuals may be improved through the administration of EPO, and this improvement appears to be independent of HgB effects...
Radioprotective effects of amifostine on acute and chronic esophageal injury in rodentsZeljko Vujaskovic
Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA
Int J Radiat Oncol Biol Phys 69:534-40. 2007..This study was performed to evaluate the protective benefit of amifostine against esophageal injury from fractionated radiation in a rodent model...
Development and clinical evaluation of a three-dimensional cone-beam computed tomography estimation method using a deformation field mapLei Ren
Department of Radiation Oncology, Henry Ford Health System, Detroit, MI, USA
Int J Radiat Oncol Biol Phys 82:1584-93. 2012..To develop a three-dimensional (3D) cone-beam computed tomography (CBCT) estimation method using a deformation field map, and to evaluate and optimize the efficiency and accuracy of the method for use in the clinical setting...
Preoperative radiotherapy and bevacizumab for angiosarcoma of the head and neck: two case studiesBridget F Koontz
Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina, USA
Head Neck 30:262-6. 2008..Given the vascular nature of angiosarcoma and the need for better treatment of this disease, we investigated the concurrent use of bevacizumab with preoperative radiotherapy for head and neck angiosarcoma...
Concurrent chemoradiotherapy for locally advanced, nonmetastatic, squamous carcinoma of the head and neck: consensus, controversy, and conundrumDavid M Brizel
Department of Radiation Oncology and the Division of Otolaryngology, Duke University Medical Center, Durham, NC 27710, USA
J Clin Oncol 24:2612-7. 2006..Epidermal growth factor receptor blockade enhances the effectiveness of RT alone. Its role and that of angiogenic blockade in CRT are under investigation...
Multiple etiologies of tumor hypoxia require multifaceted solutionsMark W Dewhirst
Department of Radiation Oncology and Biomedical Engineering, Duke University, Durham, NC 27710, USA
Clin Cancer Res 13:375-7. 2007
Influence of intravenous amifostine on xerostomia, tumor control, and survival after radiotherapy for head-and- neck cancer: 2-year follow-up of a prospective, randomized, phase III trialTodd H Wasserman
Department of Radiation Oncology, Washington University, St Louis, MO 63110 1046, USA
Int J Radiat Oncol Biol Phys 63:985-90. 2005....
Effect of longitudinal oxygen gradients on effectiveness of manipulation of tumor oxygenationKristian Erickson
Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina 27710, USA
Cancer Res 63:4705-12. 2003..Therefore, the tumor surface is refractory to improvement in pO(2) with this method. Additional refinements may be needed to improve pO(2) of analogous regions in larger tumors; mechanism-driven suggestions are provided...
Induction chemotherapy: to use or not to use? That is the questionDavid M Brizel
Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA
Semin Radiat Oncol 19:11-6. 2009..Induction chemotherapy followed by concurrent chemoradiation (sequential chemoradiation) is now under investigation. The rationale and evidence supporting the choice to use or not to use a sequential program are discussed...
Dynamic contrast-enhanced MRI in head-and-neck cancer: the impact of region of interest selection on the intra- and interpatient variability of pharmacokinetic parametersOana I Craciunescu
Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA
Int J Radiat Oncol Biol Phys 82:e345-50. 2012..This work evaluates the impact of tumor ROI selection on the assessment of intra- and interpatient variability...
Paraganglioma of the head and neck: long-term local control with radiotherapyJunzo P Chino
Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA
Am J Clin Oncol 32:304-7. 2009..Due to their rarity and indolent clinical behavior, the optimal management for long-term control is unknown...
How much radiation is the chemotherapy worth in advanced head and neck cancer?Mohit Kasibhatla
Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA
Int J Radiat Oncol Biol Phys 68:1491-5. 2007..To estimate the radiotherapeutic dose equivalence of chemoradiotherapy in head and neck cancer...
M6P/IGF2R loss of heterozygosity in head and neck cancer associated with poor patient prognosisTimothy A Jamieson
Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USA
BMC Cancer 3:4. 2003..The purpose of this investigation was to determine if the M6P/IGF2R tumor suppressor gene is mutated in human head and neck cancer, and if allelic loss is associated with poor patient prognosis...
Thermochemoradiotherapy improves oxygenation in locally advanced breast cancerEllen L Jones
Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina, USA
Clin Cancer Res 10:4287-93. 2004..Hyperthermia may offer a strategy for improving tumor reoxygenation with consequent treatment response. However, the effect of hyperthermia on tumor reoxygenation appears to depend on thermal dose and requires additional investigation...
The potential role of intrinsic hypoxia markers as prognostic variables in cancerEui Jung Moon
Department of Pathology, Duke University Medical Center, Durham, North Carolina 27710, USA
Antioxid Redox Signal 9:1237-94. 2007..In conclusion, this review suggests the need for further studies with standardized methods to examine gene expression, as well as the use of multiple gene expressions...
Controversies in the locoregional management of head and neck cancerDavid M Brizel
Department of Radiation Oncology, Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina 27710, USA
J Natl Compr Canc Netw 9:653-62. 2011..Recent data support the use of surgery in the presence of a positive posttreatment PET, and observation in the setting of a negative posttreatment scan...
Review of methods used to study oxygen transport at the microcirculatory levelM W Dewhirst
Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina 27710, USA
Int J Cancer 90:237-55. 2000....
Ultrasound guided pO2 measurement of breast cancer reoxygenation after neoadjuvant chemotherapy and hyperthermia treatmentZ Vujaskovic
Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA
Int J Hyperthermia 19:498-506. 2003..The results of this preliminary study suggest that the combination of neoadjuvant chemotherapy and hyperthermia improves oxygenation in locally advanced breast tumours that are initially hypoxic...
The treatment of high-grade soft tissue sarcomas with preoperative thermoradiotherapyL R Prosnitz
Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA
Int J Radiat Oncol Biol Phys 45:941-9. 1999..To explore the use of a novel program of preoperative radiation and hyperthermia in the management of high-grade soft tissue sarcomas (STS)...
FDG-PET assessment of the effect of head and neck radiotherapy on parotid gland glucose metabolismMichael C Roach
School of Medicine, Duke University Medical Center, Duke University, Durham, NC 27710, USA
Int J Radiat Oncol Biol Phys 82:321-6. 2012..The goal of this retrospective study was to identify the radiation dose-response relationship of parotid gland glucose metabolism in patients with head and neck squamous cell carcinoma (HNSCC)...
Interlaboratory variation in oxygen tension measurement by Eppendorf "Histograph" and comparison with hypoxic markerM Nozue
Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, USA
J Surg Oncol 66:30-8. 1997..These results were also compared to the immunohistochemical staining of 2-nitromidazole adducts...
The role of amifostine as a radioprotectorT H Wasserman
Department of Radiation Oncology, Washington University Medical Center, St. Louis, Missouri 63110, USA
Oncology (Williston Park) 15:1349-54; discussion 1357-60. 2001..This article will review the current understanding of the nature of toxicity resulting from radiation therapy and the benefits that can be derived from using protection to increase the tolerance of normal tissue to radiation damage...
Simultaneous administration of glucose and hyperoxic gas achieves greater improvement in tumor oxygenation than hyperoxic gas aloneS A Snyder
Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA
Int J Radiat Oncol Biol Phys 51:494-506. 2001..However, some cell lines are not susceptible to the Crabtree effect, and the magnitude is dependent on baseline pO(2). Additional or alternative manipulations may be necessary to achieve more uniform improvement in pO(2)...
A phase II trial testing the thermal dose parameter CEM43 degrees T90 as a predictor of response in soft tissue sarcomas treated with pre-operative thermoradiotherapyP D Maguire
Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA
Int J Hyperthermia 17:283-90. 2001..Possible explanations for this outcome are discussed...
The mechanisms by which hyperbaric oxygen and carbogen improve tumour oxygenationD M Brizel
Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina 27710, USA
Br J Cancer 72:1120-4. 1995..Sympathetic-mediated vasoconstriction during hyperbaric carbogen caused it to be less effective than HBO. This mechanism also appeared to operate during normobaric carbogen breathing...
Radiation induces aerobic glycolysis through reactive oxygen speciesJim Zhong
School of Medicine, Duke University, Durham, USA
Radiother Oncol 106:390-6. 2013..Here we tested whether concurrent use of this drug with radiotherapy would reduce the switch to a glycolytic phenotype...
Head and neck cancer as a model for advances in imaging prognosis, early assessment, and posttherapy evaluationDavid M Brizel
Duke University Cancer Institute, Durham, NC, 27710, USA
Cancer J 17:159-65. 2011....
The role of adaptive and functional imaging modalities in radiation therapy: approach and application from a radiation oncology perspectiveDavid S Yoo
Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USA
Semin Ultrasound CT MR 31:444-61. 2010..At the same time, no imaging technique can address all the uncertainties inherent in cancer therapy. The application, interpretation, and limitations of various imaging modalities are discussed from a radiation oncology perspective...
On-board patient positioning for head-and-neck IMRT: comparing digital tomosynthesis to kilovoltage radiography and cone-beam computed tomographyQ Jackie Wu
Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA
Int J Radiat Oncol Biol Phys 69:598-606. 2007..This clinical study evaluated DTS as a daily imaging technique for patient positioning and compared the results with 3D CBCT and two-dimensional (2D) radiography...
Radioprotection of lungs by amifostine is associated with reduction in profibrogenic cytokine activityZeljko Vujaskovic
Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina 27710, USA
Radiat Res 157:656-60. 2002..Future studies are needed to determine whether administration of amifostine both during and after radiotherapy may further increase its radioprotective effect...
A mathematical model of tumor oxygen and glucose mass transport and metabolism with complex reaction kineticsJohn P Kirkpatrick
Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina 27710, USA
Radiat Res 159:336-44. 2003..This model demonstrates that hypoxia is quite sensitive to metabolic rate and geometric factors. It also predicts quantitatively the effects of inhibited oxygen metabolism and enhanced mass transfer on tumor oxygenation...
Is there a role for selective neck dissection after chemoradiation for head and neck cancer?K Thomas Robbins
J Am Coll Surg 199:913-6. 2004
A Phase II trial of subcutaneous amifostine and radiation therapy in patients with head-and-neck cancerPramila Rani Anne
Thomas Jefferson University Hospital, Bodine Center for Cancer Research, Philadelphia, PA 19107, USA
Int J Radiat Oncol Biol Phys 67:445-52. 2007..Intravenous amifostine 200 mg/m2 reduces xerostomia in head-and-neck cancer patients. This Phase II study evaluated subcutaneous (s.c.) amifostine in a similar patient population...
